Home/Filings/4/0001955265-25-000004
4//SEC Filing

DELANEY MARK E 4

Accession 0001955265-25-000004

CIK 0001022079other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:28 PM ET

Size

11.9 KB

Accession

0001955265-25-000004

Insider Transaction Report

Form 4
Period: 2025-11-18
DELANEY MARK E
SVP & Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-18$143.33/sh+100$14,33315,476 total
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2025-11-18$144.47/sh7,846$1,133,5120 total
    Exercise: $144.47Exp: 2032-03-21Common Stock (7,846 underlying)
  • Sale

    Common Stock

    2025-11-18$187.35/sh7,946$1,488,6837,530 total
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2025-11-18$143.33/sh100$14,3337,484 total
    Exercise: $143.33Exp: 2033-02-23Common Stock (100 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-18$144.47/sh+7,846$1,133,51215,376 total
Footnotes (2)
  • [F1]This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
  • [F2]The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Issuer

QUEST DIAGNOSTICS INC

CIK 0001022079

Entity typeother

Related Parties

1
  • filerCIK 0001955265

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:28 PM ET
Size
11.9 KB